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leukocyte count at the onset of fever was the significant 
risk factor of the septic shock in the patient with 
neutropenic fever. 
Conclusion: As the most common pathogen of the septic 
shock was gram-negative bacteria, especially E. coli, 
more prudent use of glycopeptide might be needed in 
hypotensive patient if there was no evidence of gram- 
positive infection. 
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Purpose: To study the antibacterial resistance pattern 
induced in P aeruginosa following exposure to cipro- 
floxacin. 
Methods: %enty-six clinical isolates of ciprofloxacin- 
susceptible P aeruginosa were exposed to increasing 
concentrations of ciprofloxacin (0.125-4 &ml) over 
a ten day period. Minimum inhibitory concentration 
(MIC) values were determined for ciprofloxacin, 
cefepime, tobramycin, and garenoxacin before and after 
ciprofloxacin exposure. 
Results: 24 out of 26 isolates developed ciprofloxacin 
resistance (final MIC values, 8-64 ug/ml). The MIC 
values prior to ciprofloxacin-exposure were (0.125-4 
for garenoxacin, 0.5-8 kg/ml for 24 out of 26 isolates 
for cefepime, and (0.125-l &ml for tobramycin. Post- 
ciprofloxacin exposure, all isolates demonstrated 
elevated garenoxacin MIC values (8->128 pg/ml). Of 
the 24 cefepime-susceptible isolates, 12 exhibited a >2- 
fold increase in the cefepime MIC values following 
exposure to ciprofloxacin (four became intermediately- 
susceptible to cefepime, and one became cefepime- 
resistant). No changes in tobramycin MIC values were 
recorded. 
Conclusion: The use of ciprofloxacin may induce resist- 
ance to non-quinolone classes of antimicrobial agents in 
P aeruginosa. 
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Mucosal barrier injury (MBI) of the mouth and gut is a 
severe and dose-limiting complication of the ablative 
regimens used to prepare for hematopoietic stem 
cell transplant (HSCT). Gut MB1 results in increased 
permeability of large molecules and decreased absorption 
of smaller molecules. Here we describe the onset of 
gram-positive bacteremia in relation to changes in gut 
permeability and absorption as measured by a multi- 
sugar test. 
Study population: 9 subjects (IDA group) received 
cyclophosphamide 60 mg/kg i.v on days 6 and 5 and total 
body irradiation with 4.5 Gy on days 2 and 1. 
Antithymocyte-globulines (2 mg/kg i.v. on days 8 till 5) 
was given to 4 of them as they were to receive a 
voluntary unrelated transplant. Another 9 subjects were 
given idarubicin (+IDA) 42 mg/M2 by continuous 
infusion for 48 hours on day 12 before cyclophosphamide 
and TBI in preparation for a human leukocyte antigen 
(HLA) matched, mixed lymphocyte culture (MLC) 
negative T-cell depleted sibling HSCI’. All were managed 
throughout the study period with a triple-lumen central 
venous catheter (CVC) that was inserted on day of 
admission. 
Methods: Multi-sugar probes: Before starting chemo- 
therapy (baseline) and on days 7 (only IDA+), 0, +7, 
+14, +21 post HSCT subjects emptied their bladders, 
after an overnight fast and then drank an isotonic 
solution consisting of 5 g lactulose, 1 g L-rhamnose, 0.2 
g 3-0-methylglucose, 0.5 g D-xylose in 100 mL. Urine 
was then collected over 5 h, the total output was 
recorded and an aliquot was stored at 80°C. The sugars 
were detected using high-performance liquid chromato- 
graphy and the fluorescence label 9-fluorenylmethyl 
chloroformate hydrazine. Lactulose/rhamnose (L/R) 
ratios were used as an index of gut integrity. 
Bacteremia: Blood was drawn through each lumen of 
the CVC for culture twice-weekly and also peripherally 
at the onset of fever. Bacteremia was considered present 
when any organism was recovered from a single blood 
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culture including coagulase-negative staphylococci 
(CONS). 
Supportive care: Antimicrobial prophylaxis consisted of 
oral ciprofloxacin 500 mg q12h from admission. 17 
patients were given cefepime 2g q8h i.v. empirically. 
The pattern of onset of OVS bacteremia is more or 
less the same in both groups but only in the +IDA group 
did the onset of CONS bacteremia equal that of the 
OVS. Only in the +IDA group the mean L/R ratio was 
significantly higher on days 0,7 14 and 21 (p ~0.05) with 
respect to baseline but also on day +2lwith respect to 
the -IDA group. 
Conclusion: Gram-positive bacteremia occurred pre- 
dominantly within the first 2 weeks after transplant 
when gut integrity was perturbed. The onset of OVS 
bacteremia was not influenced by the administration of 
idarubicin although there were markedly more episodes 
of CONS bacteremia when L/R ratios were elevated 
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Resistance patterns of 822 strains of I? aeruginosa iso- 
lated from cancer patients in 1996-2001 were analysed. 
Resistance to widely used antimicrobial-ceftazidime 
(CAZ) - was 29.5% in 1996-1997; 31.5% in 1998-1999 
and 22.3% in 2000-2001 (p~O.Ol-O.001). Decreasing of 
resistance level to CAZ may be explained by increasing 
usage of cefepime (CPM) in the last 2.5 years. Resistance 
of P aeruginosa to CPM in 2000-2001 didn’t differ 
significantly from that of CAZ (17.2% vs 22.3%, 
p >0.05). Imipenem (IMP) in 2000-2001 was significantly 
more active compared to CAZ (12.9% vs 22.3%, 
p<O.OOOl). Higher level of resistance of P aeruginosa 
compared to CAZ was seen in 2000-2001 to cefoperazone 
(49.4% vs 22.3%,pcO.O001), amikacin (43.0% vs 22.3%, 
pcO.OOOl), ciprofloxacin (57.5% vs 22.3%, p<O.OOOl) 
and meropenem (39.3% vs 22.3%,p<O.O001). Resistance 
rate to last three antimicrobials increased during last 6 
years: amikacin-from 16.7% to 43.0%, ciprofloxacin- 
from 28.9% to 57.5%) and meropenem - from 17.8% to 
39.3% (pcO.0001 for all comparisons). Resistance rate 
of I? aeruginosa to CAZ during 2000 and 2001 was the 
highest in ICU compared to all departments of the 
hospital (33.3% vs 22.3%, pcO.01). Higher rate of 
resistant strains of I? aeruginosa was found in 2000-2001 
in bronchoscopic materials (34.3%, ~~0.02) than in 
other ones. Thus, the surveillance data show that only 
three from abovementioned antimicrobials (CAZ, CPM, 
IMP) maintain their activity against I? aeruginosa strains 
isolated from cancer patients in our hospital. Massive 
usage of other antibiotics such as amikacin, ciprofloxacin 
and meropenem resulted in progressive loss of suscepti- 
bility to them. Probably rational restriction policy is 
needed. 
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Nosocomial outbreak of legionella pneumonia caused 
by legionella pneumophila serogroup 3 occurred in 
four patients after bone marrow transplantation for 
hematologic malignancies in a new bone marrow 
transplantation (BMT) unit during a period of two 
weeks (18/6/00-2/7/00). Diagnosis was established by 
culture of bronchoalveolar lavage (BAL) fluid. Legionella 
pneumophila serogroup 3 was recovered from the water 
supply system to the same unit just before the outbreak. 
Serologic screening revealed no other cases of legionella 
pneumonia in 19 consecutive BMT patients hospitalized 
in the same unit at the same time, giving a frequency of 
infection of 17%. Immediately after the outbreak was 
recognized, tap water use was forbidden, and cipro- 
floxacin prophylaxis was started for all patients in the 
unit, until decontamination of the water was achieved 
by hyperchlorination and superheating. No further 
cases were detected. Later on two more nosocomially 
acquired sporadic cases occurred, on ll/OO and 2/01, 
along with reemergence of legionella in the water. 
Conclusion: Contamination of hospital water supply 
system with legionella carries a high risk for legionella 
pneumonia among BMT patients. Early recognition of 
the outbreak, immediate restrictions over water use, 
antibiotic prophylaxis for all non-infected patients, and 
water decontamination, successfully terminated the out- 
break. Permanent (as opposed to intermittent) decon- 
tamination measures should be taken in order to prevent 
nosocomial legionella pneumonia in high risk patients. 
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The aim of the study was to investigate the incidence of 
isolation of H. pylori in immunocompromised patients 
with gastrointestinal disorders using a rapid disk urease 
test and comparing its accuracy with other methods. 
Methods: 108 patients with MALT lymphomas /45/, 
gastric cancer /36/ and others /27 over the age of 65 were 
studied. Two biopsy specimens for each patient were 
taken from gastric antrum and corpus and were tested 
for H. pylori. By culture, histology and by the rapid disk 
